Encouraging patients with asthma to take a greater part in the management of their own disease has become part of asthma care in the past few years, and is emphasised in recent consensus statements both in the UK and elsewhere.'1This concept of self-management has been commonplace in the USA for some time" but has largely been restricted to non-therapeutic measures and actions taken in emergency situations -an area shown to be poorly perceived by patients.8 Self-management of this sort did not include altering anti-inflammatory drug dosages in response to home peak flow monitoring.
Beasley et al in 1989 published the first positive results of such peak flow based selfmanagement in the UK using a small uncontrolled sample of adults with moderate to severe asthma attending a hospital outpatient clinic.9 This work led to a number of cautious endorsements of peak flow based self-management, all accompanied by strong calls for more evidence of effectiveness."-" Charlton et al subsequently compared peak flow and symptom based self-management schemes in general practice and did not find any significant differences between the two approaches."3 Another primary care study was unable to show beneficial outcomes from self-management in a nurse-run asthma clinic."4 More recent evidence has questioned the accuracy of the currently available peak flow meters'516 and of the records patients produce with them.'7 The effectiveness of self-management was also put in doubt by the GRASSIC study of shared care between hospital specialists and general practitioners which concluded that "prescribing peak flow meters and giving self management guidelines to all asthma patients is unlikely to improve mortality or morbidity". '8 This UK view is in contrast to the benefits from self-management in the community shown recently in New Zealand by Beasley et al, '9 although subjects in that study showed little preference between self-management plans based on peak flow or symptoms only.
Most asthma care at all ages is provided in general practice. Repeat morbidity and quality of life questionnaire and usage of medical resources questionnaire (by GP/nurse).
4,

Contact 6 a
Questionnaire to GP and to patient concerning acceptability and usefulness of PEFR self-management. In the self-management group the 14 day peak flow record was examined and a best or "potential normal value" (PNV) established. This value was the highest morning or evening value on the chart unless it was more than 50 1/min above the next highest, in which case the next highest was taken.
Each patient in the self-management group was taught how to alter their regime in a manner similar to that of Beasley et al9 on the basis of the best of three peak flow manoeuvres each morning as summarised in fig 2. The written instructions also advised the patients to seek an extra consultation with their general practitioner if their peak flow had not risen above 75% after 14 days of oral steroids or 28 days of double dose inhaled steroids.
All patients were asked to keep daily diary cards recording data on morbidity and bronchodilator use for 26 weeks. Cough, wheeze, and shortness of breath were scored on a four point scale (0-3) per day; actual numbers of bronchodilator doses were requested; and night waking, activity restriction, and time off work or school were scored 1 or 0 for each day.
After visit 5, the use of medical resources and prescribing data were extracted from their NHS practice records. The duration of each study consultation was measured using a stopwatch.
All data were rendered anonymous and analysed on an IBM compatible personal computer using the SPSS-PC + version 3 package. whole study protocol (33 in the self-management group and 39 in the planned visits group) but diary card data for at least three months were available on a further 12 (six in each group), so these are included in the analysis of this part of the data. There were no significant demographic or initial lung function differences between the two study groups in the "completers" (table  1) . The median and modal initial total daily steroid doses were 400 j.g in both groups. The "non-completers" tended to be younger, more often male (X2=4-08, p<0-05) and to have lower initial FVC values than the "completers", but were otherwise similar and came from the two groups equally (table 2) .
LUNG FUNCTION
Lung function tended to improve between visits 1 and 2 as a result of the oral steroid course and to decline between visits 2 and 5 at the end of the study (table 3) . No significant intergroup differences were found but the rises in peak flow rate, FEV1, and FVC between visits 1 and 2 in the planned visits group only were statistically significant (p<0-05). The decline in FVC in the self-management group and the decline in FEV1 in the planned visits group between visits 2 and 5 were also significant (p<0 05). No statistically significant within group differences were noted in either group when visits 1 and 5 were compared. For each patient a total for each symptom across the study period was divided by the number of days for which diary data was available multiplied by 28 to give a monthly rate.
further three complied during at least half of their episodes (67% "compliers" in total). Eight never complied. Only 10 instances of peak flows of 50% PNV or below were recorded in total.
DOCTOR S AND PATIENTS' VIEWS ON PEAK FLOW BASED SELF-MANAGEMENT
Three months after the study period 27 (82%) of the self-management group felt that the peak flow meter had been helpful to them and four (18%) did not. Twenty nine (88%) still knew where their peak flow meter was and 13 (39%) had altered their treatment on the basis of peak flow readings since the study ended. Five subjects had not used their peak flow meter since the study ended but 18 (56%) had used it in the two weeks prior to their postal questionnaire, and a further three within four weeks. Five had not used it for a longer period and data on two were missing. Twenty eight (85%) of the subjects' doctors felt that the peak flow meter had been helpful in their asthma management.
USE OF RESOURCES
Study visits were conducted by the nurse only in 15 cases in the self-management group, by the doctor only in 1 1, and by both in two (data missing in five cases); the equivalent figures for the planned visits group were 23, 13, and 2, respectively (one case missing). Visit 2, at which self-management was taught in that group, was significantly longer than in the planned visits group (median 14-2 minutes (interquartile range 10-0-19-3 minutes) versus 10-0 (7 9-13-9), z=2 7, p=0-01). Data on prescribing costs were incomplete but, again, no intergroup differences were evident. The numbers of subjects using oral steroids during the study period were similar in groups where these data were available (nine of 19 in the self-management group, 10 of 26 in the planned visit group, %2 0-36, p=0Q55). The numbers of home visits, outpatient attendances, admissions, and rescue nebulisations were too small for useful intergroup comparisons. Data on asthma consultations in excess of study requirements were inconsistent, but no significant differences seemed likely on the basis ofthe limited analysis possible.
Discussion
Despite the considerable enthusiasm shown for home peak flow monitoring by both patients and their doctors in this study, our data do not show any major advantage for this procedure over and above a more traditional approach with proactive care. Beasley's original results were not reproduced in this sample of patients from general practice, and the cost effectiveness of giving peak flow based self-management plans to all patients with asthma is clearly questionable. We were, however, only able to recruit the minimum required number of subjects to the study and their starting levels of lung function and morbidity were better than expected. Post hoc calculations suggest that the magnitude of change (or difference between groups) detectable at 5% significance and 80% power, given our sample size, was 13 points for FEV1 percentage predicted, 25% for night wakening, and 30% for days off work or school. Though we have clearly shown that differences of this size between the groups did not appear, smaller differences than these may be considered to be both clinically relevant and cost effective.
The study was launched in the summer following the new contract for general practice26
and our initial contacts with practices found them overwhelmed with new work and less than usually inclined to take part in research. What we have shown is that long term home peak flow recording among milder asthmatic subjects cared for in general practice is unlikely to be the main answer to the continuing problem of morbidity from the disease. More of our study subjects complied with once daily peak flow measurement than the 25% shown by McKinley in another community study, but his protocol required three times daily monitoring. 28 Our data and those of other recent studies'819 allow a number of observations to be made. The sort of widespread rigid adherence to peak flow based self-management initially emphasised after Beasley's work is no longer necessary for all asthma sufferers. We now know that large impacts on morbidity and mortality are unlikely with this form of self-management, and have some idea of what proportion of patients will adhere to regular home monitoring outside the confines of a trial. The original Beasley plan had peak flow levels of 70% and 50% to trigger change. These values were guestimates and now appear too low. The recently revised UK guidelines recommend 60% as the point at which oral steroids should be commenced, reflecting the opinions of experts altered more by practice rather than research.
Partridge has recently identified "several unknowns regarding self-management", namely "the need to define better who needs a peak flow meter, who needs a self-management plan, and what steps and interventions the plans should contain".2' His advice to give detailed self-management plans and peak flow meters "to adults with severe asthma, to those with variable disease, and to those who have been admitted to hospital because of asthma" seems eminently sensible for now, although those felt to have poor perception of the severity of their asthma might also be included. A much simplified self-management plan may be more appropriate for most milder asthma sufferers, but perhaps also the concept of self-management may need refinement.
There are two reasons for monitoring peak flow in patients with chronic asthma. The first is to anticipate severe deteriorations and prevent crises and the second is to monitor control while in relative remission to establish the appropriate treatment to gain maximum symptom relief. These probably require separate approaches. A single low reading should trigger a response relevant to the time scale of rapid deterioration -for example, re-measurement after bronchodilator use or after a short interval, and oral corticosteroids if recovery is not satisfactory. A single low reading is not a sufficient signal to increase baseline therapy, the need for which should be judged over a longer period.
If we are to make the best use of inevitably limited resources in primary care for the better management of asthma, efforts to define outcome measures and to target care as a result of their use must continue. Some research has already examined this issue2230 and more is in progress or planned. This needs to include further exploration of why both patients and doctors give strong support to home peak flow monitoring, as shown by this study. The results will help to assess the proper place for peak flow based self-management in asthma.
